Dramatic clinical and radiographic response to BRAF inhibition in a patient with progressive disseminated optic pathway glioma refractory to MEK inhibition.

作者: Abhishek Bavle , Jeremy Jones , Frank Y. Lin , Amy Malphrus , Adekunle Adesina

DOI: 10.1080/08880018.2017.1360971

关键词:

摘要: While clinical and radiographic responses to agents targeting the mitogen-activated protein kinases (MAPK) pathway have been repor-ted in pediatric low-grade gliomas (LGG), early phase trials indicate refractoriness these medications some of patients. We report a patient with disseminated LGG BRAFV600E mutation, which was refractory selumetinib, MEK inhibitor, but subsequently showed immediate response dabrafenib, BRAF sustained effect for 9 months prior progression. In LGGs, treatment resistance one agent MAPK might not imply other this pathway.

参考文章(22)
Cora Mirow, Torsten Pietsch, Susanne Berkefeld, Robert Kwiecien, Monika Warmuth-Metz, Fabian Falkenstein, Barbara Diehl, Stephan von Hornstein, Astrid K. Gnekow, Children <1 year show an inferior outcome when treated according to the traditional LGG treatment strategy: A report from the german multicenter trial HIT‐LGG 1996 for children with low grade glioma (LGG) Pediatric Blood & Cancer. ,vol. 61, pp. 457- 463 ,(2014) , 10.1002/PBC.24729
Pratiti Bandopadhayay, Guillaume Bergthold, Wendy B. London, Liliana C. Goumnerova, Andres Morales La Madrid, Karen J. Marcus, Dongjing Guo, Nicole J. Ullrich, Nathan J. Robison, Susan N. Chi, Rameen Beroukhim, Mark W. Kieran, Peter E. Manley, Long-term outcome of 4,040 children diagnosed with pediatric low-grade gliomas: an analysis of the Surveillance Epidemiology and End Results (SEER) database Pediatric Blood & Cancer. ,vol. 61, pp. 1173- 1179 ,(2014) , 10.1002/PBC.24958
Omar Chamdine, Alberto Broniscer, Shengjie Wu, Amar Gajjar, Ibrahim Qaddoumi, Metastatic Low-Grade Gliomas in Children: 20 Years' Experience at St. Jude Children's Research Hospital. Pediatric Blood & Cancer. ,vol. 63, pp. 62- 70 ,(2016) , 10.1002/PBC.25731
David TW Jones, Barbara Hutter, Natalie Jäger, Andrey Korshunov, Marcel Kool, Hans-Jörg Warnatz, Thomas Zichner, Sally R Lambert, Marina Ryzhova, Dong Anh Khuong Quang, Adam M Fontebasso, Adrian M Stütz, Sonja Hutter, Marc Zuckermann, Dominik Sturm, Jan Gronych, Bärbel Lasitschka, Sabine Schmidt, Huriye Şeker-Cin, Hendrik Witt, Marc Sultan, Meryem Ralser, Paul A Northcott, Volker Hovestadt, Sebastian Bender, Elke Pfaff, Sebastian Stark, Damien Faury, Jeremy Schwartzentruber, Jacek Majewski, Ursula D Weber, Marc Zapatka, Benjamin Raeder, Matthias Schlesner, Catherine L Worth, Cynthia C Bartholomae, Christof Von Kalle, Charles D Imbusch, Sylwester Radomski, Chris Lawerenz, Peter Van Sluis, Jan Koster, Richard Volckmann, Rogier Versteeg, Hans Lehrach, Camelia Monoranu, Beate Winkler, Andreas Unterberg, Christel Herold-Mende, Till Milde, Andreas E Kulozik, Martin Ebinger, Martin U Schuhmann, Yoon-Jae Cho, Scott L Pomeroy, Andreas Von Deimling, Olaf Witt, Michael D Taylor, Stephan Wolf, Matthias A Karajannis, Charles G Eberhart, Wolfram Scheurlen, Martin Hasselblatt, Keith L Ligon, Mark W Kieran, Jan O Korbel, Marie-Laure Yaspo, Benedikt Brors, Jörg Felsberg, Guido Reifenberger, V Peter Collins, Nada Jabado, Roland Eils, Peter Lichter, International Cancer Genome Consortium PedBrain Tumor Project Pfister Stefan M s. pfister@ dkfz-heidelberg. de 1 12 b, Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma Nature Genetics. ,vol. 45, pp. 927- 932 ,(2013) , 10.1038/NG.2682
Ramin Nazarian, Hubing Shi, Qi Wang, Xiangju Kong, Richard C. Koya, Hane Lee, Zugen Chen, Mi-Kyung Lee, Narsis Attar, Hooman Sazegar, Thinle Chodon, Stanley F. Nelson, Grant McArthur, Jeffrey A. Sosman, Antoni Ribas, Roger S. Lo, Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation Nature. ,vol. 468, pp. 973- 977 ,(2010) , 10.1038/NATURE09626
Jinghui Zhang, Gang Wu, Claudia P Miller, Ruth G Tatevossian, James D Dalton, Bo Tang, Wilda Orisme, Chandanamali Punchihewa, Matthew Parker, Ibrahim Qaddoumi, Fredrick A Boop, Charles Lu, Cyriac Kandoth, Li Ding, Ryan Lee, Robert Huether, Xiang Chen, Erin Hedlund, Panduka Nagahawatte, Michael Rusch, Kristy Boggs, Jinjun Cheng, Jared Becksfort, Jing Ma, Guangchun Song, Yongjin Li, Lei Wei, Jianmin Wang, Sheila Shurtleff, John Easton, David Zhao, Robert S Fulton, Lucinda L Fulton, David J Dooling, Bhavin Vadodaria, Heather L Mulder, Chunlao Tang, Kerri Ochoa, Charles G Mullighan, Amar Gajjar, Richard Kriwacki, Denise Sheer, Richard J Gilbertson, Elaine R Mardis, Richard K Wilson, James R Downing, Suzanne J Baker, David W Ellison, St. Jude Children's Research Hospital–Washington University Pediatric Cancer Genome Project, Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas Nature Genetics. ,vol. 45, pp. 602- 612 ,(2013) , 10.1038/NG.2611
A. J. Sievert, S.-S. Lang, K. L. Boucher, P. J. Madsen, E. Slaunwhite, N. Choudhari, M. Kellet, P. B. Storm, A. C. Resnick, Paradoxical activation and RAF inhibitor resistance of BRAF protein kinase fusions characterizing pediatric astrocytomas Proceedings of the National Academy of Sciences of the United States of America. ,vol. 110, pp. 5957- 5962 ,(2013) , 10.1073/PNAS.1219232110
Stephan von Hornstein, Rolf-D. Kortmann, Torsten Pietsch, Angela Emser, Monika Warmuth-Metz, Niels Soerensen, Ronald Straeter, Norbert Graf, Barbara Thieme, Astrid K. Gnekow, Impact of chemotherapy on disseminated low-grade glioma in children and adolescents: report from the HIT-LGG 1996 trial. Pediatric Blood & Cancer. ,vol. 56, pp. 1046- 1054 ,(2011) , 10.1002/PBC.23006
A. Kaul, Y.-H. Chen, R. J. Emnett, S. Dahiya, D. H. Gutmann, Pediatric glioma-associated KIAA1549:BRAF expression regulates neuroglial cell growth in a cell type-specific and mTOR-dependent manner. Genes & Development. ,vol. 26, pp. 2561- 2566 ,(2012) , 10.1101/GAD.200907.112
Jean M. Mulcahy Levy, Joshua C. Thompson, Andrea M. Griesinger, Vladimir Amani, Andrew M. Donson, Diane K. Birks, Michael J. Morgan, David M. Mirsky, Michael H. Handler, Nicholas K. Foreman, Andrew Thorburn, Autophagy inhibition improves chemosensitivity in BRAF(V600E) brain tumors. Cancer Discovery. ,vol. 4, pp. 773- 780 ,(2014) , 10.1158/2159-8290.CD-14-0049